title: Drug-eluting stent thrombosis after 2029 days of placement: longest ever reported interval between drug-eluting stent placement and very late thrombosis.
abstract: In this era of very wide-spread use of percutaneous coronary intervention for the management of coronary artery disease, the appropriate duration of antiplatelet therapy after drug-eluting stent implantation still remains a subject of debate. Current recommendations from the American College of Cardiology/American Heart Association (2007) is to continue treatment with aspirin and clopidogrel for 1 year and then continue with aspirin only. However, cases of very late stent thrombosis (more than 12 months postimplantation) are being increasingly reported in literature. In this article we report a case of thrombosis as a result of drug-eluting stent placement after almost 67 months (2029 days), which to our knowledge, is the longest reported duration between the implantation of drug-eluting stent and occurrence of vascular event associated with very late stent thrombosis.
authors: Department of Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA.
authors: Muhammed
authors: M
authors: Akhtar
authors: Alain
authors: A
authors: Waked
authors: Hilal
authors: H
authors: Bhat
authors: Mariam
authors: M
authors: Khalid
authors: Sumaya
authors: S
authors: Teli
authors: Faisal B
authors: FB
authors: Saiful
authors: James
authors: J
authors: Lafferty
authors: Tariq
authors: T
authors: Bhat
mesh_terms: D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D006328:Cardiac Catheterization; D017023:Coronary Angiography; D003324:Coronary Artery Disease / Q000000981:diagnostic imaging / Q000601:surgery*; D003937:Diagnosis, Differential; D054855:Drug-Eluting Stents; D004562:Electrocardiography; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011475:Prosthesis Failure; D013927:Thrombosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D013997:Time Factors